Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Proc Natl Acad Sci U S A ; 118(39)2021 09 28.
Artículo en Inglés | MEDLINE | ID: mdl-34548395

RESUMEN

Extracellular adenosine triphosphate (ATP) released by mucosal immune cells and by microbiota in the intestinal lumen elicits diverse immune responses that mediate the intestinal homeostasis via P2 purinergic receptors, while overactivation of ATP signaling leads to mucosal immune system disruption, which leads to pathogenesis of intestinal inflammation. In the small intestine, hydrolysis of luminal ATP by ectonucleoside triphosphate diphosphohydrolase (E-NTPD)7 in epithelial cells is essential for control of the number of T helper 17 (Th17) cells. However, the molecular mechanism by which microbiota-derived ATP in the colon is regulated remains poorly understood. Here, we show that E-NTPD8 is highly expressed in large-intestinal epithelial cells and hydrolyzes microbiota-derived luminal ATP. Compared with wild-type mice, Entpd8-/- mice develop more severe dextran sodium sulfate-induced colitis, which can be ameliorated by either the depletion of neutrophils and monocytes by injecting with anti-Gr-1 antibody or the introduction of P2rx4 deficiency into hematopoietic cells. An increased level of luminal ATP in the colon of Entpd8-/- mice promotes glycolysis in neutrophils through P2x4 receptor-dependent Ca2+ influx, which is linked to prolonged survival and elevated reactive oxygen species production in these cells. Thus, E-NTPD8 limits intestinal inflammation by controlling metabolic alteration toward glycolysis via the P2X4 receptor in myeloid cells.


Asunto(s)
Adenosina Trifosfatasas/fisiología , Adenosina Trifosfato/metabolismo , Colitis/prevención & control , Glucólisis , Células Mieloides/metabolismo , Receptores Purinérgicos P2X4/metabolismo , Células Th17/inmunología , Animales , Células Cultivadas , Colitis/etiología , Colitis/metabolismo , Colitis/patología , Femenino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Células Mieloides/inmunología , Células Mieloides/patología , Receptores Purinérgicos P2X4/genética , Transducción de Señal
2.
Clin J Gastroenterol ; 17(2): 244-252, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38193986

RESUMEN

BACKGROUND: Chronic intestinal pseudo-obstruction (CIPO) is a rare intestinal disorder characterized by impaired propulsion of the digestive tract and associated with symptoms of intestinal obstruction, despite the absence of obstructive lesions. CIPO includes several diseases. However, definitive diagnosis of its etiology is difficult only with symptoms or imaging findings. CASE PRESENTATION: A 56-year-old man was referred to our hospital due to a 3-year history of continuous abdominal distention. Imaging, including computed tomography of the abdomen, and endoscopy revealed marked dilatation of the entire small intestine without any obstruction point. Therefore, he was diagnosed with CIPO. Since medical therapy didn't improve his symptoms, enterostomy and percutaneous endoscopic gastro-jejunostomy were performed. These procedures improved abdominal symptoms. However, he required home central venous nutrition due to dehydration. The pathological findings of full-thickness biopsies of the small intestine taken during surgery revealed decreased number and degeneration of ganglion cells in the normal plexus. These findings led to a final diagnosis of CIPO due to acquired isolated hypoganglionosis (AIHG). CONCLUSIONS: Here, we report the case of a patient with CIPO secondary to adult-onset AIHG of the small intestine. Since AIHG cannot be solely diagnosed using clinical findings, biopsy is important for its diagnosis.


Asunto(s)
Obstrucción Intestinal , Seudoobstrucción Intestinal , Masculino , Adulto , Humanos , Persona de Mediana Edad , Seudoobstrucción Intestinal/etiología , Seudoobstrucción Intestinal/cirugía , Seudoobstrucción Intestinal/diagnóstico , Dilatación Patológica , Atrofia Muscular , Intestino Delgado/cirugía , Enfermedad Crónica
3.
J Clin Med ; 12(9)2023 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-37176572

RESUMEN

BACKGROUND: Mediterranean fever (MEFV) gene mutations are responsible for familial Mediterranean fever (FMF) and associated with other inflammatory diseases. However, the effects of MEFV gene mutations on intestinal Behçet's disease (BD) are unknown. In this study, we investigated these mutations and clinical features in patients with intestinal BD. METHODS: MEFV gene analysis was performed in 16 patients with intestinal BD, 10 with BD without intestinal lesions, and 50 healthy controls. Clinical features of patients with intestinal BD were retrospectively assessed. RESULTS: The rates of MEFV gene mutations in patients with intestinal BD, BD without intestinal lesions, and healthy controls were 75%, 50%, and 38%, respectively. Only 2 of 12 patients with intestinal BD harboring MEFV gene mutations (17%) were controlled without immunosuppressive treatment, while 8 patients (67%) required therapy with tumor necrosis factor (TNF) inhibitors. Among patients with intestinal BD without MEFV gene mutations (four patients), three (75%) were controlled by the administration of 5-aminosalicylic acid with or without colchicine, and one (25%) required TNF inhibitors. All patients who underwent intestinal resection had MEFV gene mutations. Immunohistochemical analysis and in situ hybridization with interleukin-1ß (IL-1ß) showed a high expression of IL-1ß only in injured areas, suggesting that IL-1ß may be involved in the formation of ulcers in patients with intestinal BD carrying MEFV gene mutations. CONCLUSION: Mutations in the MEFV gene may be associated with intestinal lesions of BD and refractoriness to treatment.

4.
Nihon Shokakibyo Gakkai Zasshi ; 109(6): 944-51, 2012 Jun.
Artículo en Japonés | MEDLINE | ID: mdl-22688171

RESUMEN

A 68-year-old woman developed acute pulmonary embolism after hepatic arterial infusion therapy for advanced hepatocellular carcinoma. Because the platelet count was significantly reduced, heparin-induced thrombocytopenia (HIT) due to heparin usage in hepatic arterial infusion therapy was clinically suspected. Subsequently, the patient tested positively for HIT antibodies, and a definitive diagnosis was obtained. Antithrombotic therapy with heparin was discontinued and treatment with argatroban was started. After the heparinized hydrophilic catheter was removed, the platelet count improved immediately. HIT should be considered when a decrease in platelet count and thrombosis are involved with the usage of heparin.


Asunto(s)
Anticoagulantes/efectos adversos , Heparina/efectos adversos , Infusiones Intraarteriales/efectos adversos , Embolia Pulmonar/etiología , Trombocitopenia/inducido químicamente , Trombocitopenia/complicaciones , Anciano , Carcinoma Hepatocelular/tratamiento farmacológico , Femenino , Heparina/administración & dosificación , Humanos , Neoplasias Hepáticas/tratamiento farmacológico
5.
Case Rep Gastroenterol ; 16(3): 637-645, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36605731

RESUMEN

Esophageal neuroendocrine neoplasms are extremely rare, and their prognosis is poor. Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are even more rare and are defined as tumors consisting of neuroendocrine carcinoma and either adenocarcinoma or squamous cell carcinoma. We report a rare case featuring endoscopic submucosal dissection (ESD) for an esophageal MiNEN, arising from the ectopic gastric mucosa in the lower thoracic esophagus. A 92-year-old male patient was referred to this hospital for investigation of an esophageal tumor. An endoscopic examination revealed a 10 mm elevated lesion, with 8 mm flat areas on the anal side, within the ectopic gastric mucosa located in the lower thoracic esophagus. ESD was carried out, and a histopathological examination revealed a tubular adenocarcinoma composed of differentiated neuroendocrine cells. Immunohistochemical staining was positive for synaptophysin and negative for chromogranin A. The labeling index of Ki-67 was more than 80%. Based on these results, we diagnosed the lesion as an esophageal MiNEN, arising in the ectopic gastric mucosa of the esophagus. The patient remains alive, without recurrence of cancer, 24 months after ESD.

6.
Hepatol Commun ; 6(5): 1198-1212, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-34837478

RESUMEN

Advanced hepatocellular carcinoma (HCC) remains a highly lethal malignancy, although several systemic therapeutic options are available, including sorafenib (SFN), which has been one of the standard treatment agents for almost a decade. As early prediction of response to SFN remains challenging, biomarkers that enable early prediction using a clinically feasible method are needed. Here, we report that the serum secretory form of clusterin (sCLU) protein and its related predictive index are potential beneficial biomarkers for early prediction of SFN response. Using high-throughput screening and subsequent multivariate analysis in the derivation cohort, we found that changes in the concentrations of CLU, vascular cell adhesion molecule-1 (VCAM1), and α-fetoprotein were significantly associated with response to SFN. Furthermore, we confirmed that an increase in CLU serum level 1 month after treatment initiation was significantly associated with shorter progression-free survival. In addition, "NR-index," which comprises these proteins, was evaluated as a tool for accurately predicting the efficacy of SFN and confirmed in the validation cohort. We also established SFN-resistant HepG2 cells (HepG2-SR) and found that sCLU significantly increased in HepG2-SR cells compared with normal HepG2 cells, and confirmed that HepG2-SR cells treated with SFN were resistant to apoptosis. The mechanism underlying activation of sCLU expression in acquired SFN resistance involves aberrant signaling and expression of Akt, mammalian target of rapamycin (mTOR), and a nutrient-related transcription factor, sterol regulatory element binding protein 1c (SREBP-1c). Furthermore, the PI3K and mTOR inhibitor BEZ235 markedly decreased sCLU expression in HepG2-SR cells. Conclusion: These results suggest that measurement of sCLU serum levels and the sCLU-related NR-index are promising clinical tools for the early prediction of SFN response in HCC. Additionally, sCLU-overexpressing HCC might be susceptible to mTOR inhibition.


Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Biomarcadores , Carcinoma Hepatocelular/tratamiento farmacológico , Clusterina/metabolismo , Humanos , Neoplasias Hepáticas/tratamiento farmacológico , Sorafenib/farmacología , Serina-Treonina Quinasas TOR/uso terapéutico
7.
Case Rep Gastroenterol ; 14(1): 103-109, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32231510

RESUMEN

Although most immune-related adverse events (irAEs) secondary to immune checkpoint inhibitors can be managed with immunosuppressive therapies; they can induce reactivation of infectious diseases, including cytomegalovirus (CMV). Here, we show a case of CMV enterocolitis during steroid therapy for an irAE. A 77-year-old man with unresectable malignant melanoma was treated with ipilimumab. He suffered from immune-related colitis (irColitis) and was treated with methylprednisolone. Although corticosteroids initially improved his symptoms, CMV reactivation occurred and colitis was exacerbated. Antiviral therapy improved his symptoms without augmenting the immunosuppressive therapy. CMV colitis should be considered when a patient with irColitis shows resistance to immunosuppressive therapy.

8.
Intern Med ; 59(20): 2499-2504, 2020 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-32581160

RESUMEN

Immune checkpoint inhibitors can affect any organ, including the salivary glands. A case of Sjögren's syndrome (SjS) induced by nivolumab for the treatment of gastric cancer is herein presented. Nivolumab treatment caused marked tumor shrinkage, but xerostomia developed after two cycles. It took 3 months after symptom onset to confirm the diagnosis of SjS. Prednisolone and pilocarpine hydrochloride did not relieve the symptoms. SjS is a relatively rare immune-related adverse event that might sometimes be overlooked. Since SjS can severely impair a patient's quality of life, oncologists should not miss any signs of salivary gland hypofunction and cooperate with specialists for SjS.


Asunto(s)
Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Nivolumab/efectos adversos , Nivolumab/uso terapéutico , Síndrome de Sjögren/inducido químicamente , Síndrome de Sjögren/tratamiento farmacológico , Neoplasias Gástricas/tratamiento farmacológico , Femenino , Humanos , Pilocarpina/uso terapéutico , Prednisolona/uso terapéutico , Glándulas Salivales/fisiopatología , Síndrome de Sjögren/inmunología , Neoplasias Gástricas/complicaciones , Neoplasias Gástricas/inmunología , Xerostomía/inducido químicamente
9.
BMJ Case Rep ; 20172017 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-28551602

RESUMEN

Mucosa-associated lymphoid tissue (MALT) lymphoma is rarely observed in the gallbladder, and its diagnosis before surgery is difficult. This report describes a case of primary MALT lymphoma of the gallbladder in an 80-year-old man. Imaging studies revealed a protruding lesion on the inside of the gallbladder, which led us to diagnose gallbladder carcinoma prior to the patient undergoing extended cholecystectomy. Microscopic examination of the resected specimen of the gallbladder demonstrated lymphoid follicles with atypical lymphocytes and the formation of lymphoepithelial lesions. These findings led to a final pathological diagnosis of primary MALT lymphoma of the gallbladder. The patient has been free of recurrence for 39 months after the surgery. Although precise diagnosis before the surgery was difficult in this case, preoperative examinations revealed a submucosal tumour-like lesion. MALT lymphomas should be considered when imaging findings are atypical for gallbladder carcinoma.


Asunto(s)
Colecistectomía , Colecistolitiasis/diagnóstico por imagen , Neoplasias de la Vesícula Biliar/diagnóstico por imagen , Vesícula Biliar/diagnóstico por imagen , Linfoma de Células B de la Zona Marginal/diagnóstico por imagen , Anciano de 80 o más Años , Diagnóstico por Imagen , Vesícula Biliar/patología , Neoplasias de la Vesícula Biliar/cirugía , Humanos , Linfoma de Células B de la Zona Marginal/cirugía , Masculino , Resultado del Tratamiento
10.
PLoS One ; 12(2): e0172509, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28225814

RESUMEN

Extracellular adenosine 5'-triphosphate (ATP) performs multiple functions including activation and induction of apoptosis of many cell types. The ATP-hydrolyzing ectoenzyme ecto-nucleotide pyrophosphatase/phosphodiesterase 3 (E-NPP3) regulates ATP-dependent chronic allergic responses by mast cells and basophils. However, E-NPP3 is also highly expressed on epithelial cells of the small intestine. In this study, we showed that E-NPP3 controls plasmacytoid dendritic cell (pDC) numbers in the intestine through regulation of intestinal extracellular ATP. In Enpp3-/- mice, ATP concentrations were increased in the intestinal lumen. pDC numbers were remarkably decreased in the small intestinal lamina propria and Peyer's patches. Intestinal pDCs of Enpp3-/- mice showed enhanced cell death as characterized by increases in annexin V binding and expression of cleaved caspase-3. pDCs were highly sensitive to ATP-induced cell death compared with conventional DCs. ATP-induced cell death was abrogated in P2rx7-/- pDCs. Accordingly, the number of intestinal pDCs was restored in Enpp3-/- P2rx7-/- mice. These findings demonstrate that E-NPP3 regulates ATP concentration and thereby prevents the decrease of pDCs in the small intestine.


Asunto(s)
Células Dendríticas/metabolismo , Intestino Delgado/citología , Hidrolasas Diéster Fosfóricas/metabolismo , Pirofosfatasas/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Caspasa 3/metabolismo , Muerte Celular/fisiología , Mucosa Intestinal/citología , Mucosa Intestinal/metabolismo , Intestino Delgado/metabolismo , Ratones , Ratones Noqueados , Ganglios Linfáticos Agregados/metabolismo , Hidrolasas Diéster Fosfóricas/genética , Pirofosfatasas/genética
11.
Mucosal Immunol ; 10(2): 446-459, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27381925

RESUMEN

Genome-wide association studies and subsequent deep sequencing analysis have identified susceptible loci for inflammatory bowel diseases (IBDs) including ulcerative colitis (UC). A gene encoding RING finger protein 186 (RNF186) is located within UC-susceptible loci. However, it is unclear whether RNF186 is involved in IBD pathogenesis. Here, we show that RNF186 controls protein homeostasis in colonic epithelia and regulates intestinal inflammation. RNF186, which was highly expressed in colonic epithelia, acted as an E3 ligase mediating polyubiquitination of its substrates. Permeability of small organic molecules was augmented in the intestine of Rnf186-/- mice. Increased expression of several RNF186 substrates, such as occludin, was found in Rnf186-/- colonic epithelia. The disturbed protein homeostasis in Rnf186-/- mice correlated with enhanced endoplasmic reticulum (ER) stress in colonic epithelia and increased sensitivity to intestinal inflammation after dextran sulfate sodium (DSS) treatment. Introduction of an UC-associated Rnf186 mutation led to impaired E3 ligase activity and increased sensitivity to DSS-induced intestinal inflammation in mice. Thus, RNF186 maintains gut homeostasis by controlling ER stress in colonic epithelia.


Asunto(s)
Proteínas Portadoras/genética , Colitis Ulcerosa/genética , Colon/patología , Estrés del Retículo Endoplásmico/genética , Células Epiteliales/fisiología , Mutación/genética , Ubiquitina-Proteína Ligasas/genética , Animales , Proteínas Portadoras/metabolismo , Células Cultivadas , Colitis Ulcerosa/inducido químicamente , Sulfato de Dextran , Modelos Animales de Enfermedad , Células Epiteliales/patología , Homeostasis , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Permeabilidad , Proteínas de Motivos Tripartitos , Ubiquitina-Proteína Ligasas/metabolismo
12.
Front Microbiol ; 8: 238, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28261190

RESUMEN

The study of mycobiota remains relatively unexplored due to the lack of sufficient available reference strains and databases compared to those of bacterial microbiome studies. Deep sequencing of Internal Transcribed Spacer (ITS) regions is the de facto standard for fungal diversity analysis. However, results are often biased because of the wide variety of sequence lengths in the ITS regions and the complexity of high-throughput sequencing (HTS) technologies. In this study, a curated ITS database, ntF-ITS1, was constructed. This database can be utilized for the taxonomic assignment of fungal community members. We evaluated the efficacy of strategies for mycobiome analysis by using this database and characterizing a mock fungal community consisting of 26 species representing 15 genera using ITS1 sequencing with three HTS platforms: Illumina MiSeq (MiSeq), Ion Torrent Personal Genome Machine (IonPGM), and Pacific Biosciences (PacBio). Our evaluation demonstrated that PacBio's circular consensus sequencing with greater than 8 full-passes most accurately reconstructed the composition of the mock community. Using this strategy for deep-sequencing analysis of the gut mycobiota in healthy Japanese individuals revealed two major mycobiota types: a single-species type composed of Candida albicans or Saccharomyces cerevisiae and a multi-species type. In this study, we proposed the best possible processing strategies for the three sequencing platforms, of which, the PacBio platform allowed for the most accurate estimation of the fungal community. The database and methodology described here provide critical tools for the emerging field of mycobiome studies.

13.
Arthritis Rheumatol ; 68(11): 2646-2661, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27333153

RESUMEN

OBJECTIVE: The intestinal microbiota is involved in the pathogenesis of arthritis. Altered microbiota composition has been demonstrated in patients with rheumatoid arthritis (RA). However, it remains unclear how dysbiosis contributes to the development of arthritis. The aim of this study was to investigate whether altered composition of human intestinal microbiota in RA patients contributes to the development of arthritis. METHODS: We analyzed the fecal microbiota of patients with early RA and healthy controls, using 16S ribosomal RNA-based deep sequencing. We inoculated fecal samples from RA patients and healthy controls into germ-free arthritis-prone SKG mice and evaluated the immune responses. We also analyzed whether the lymphocytes of SKG mice harboring microbiota from RA patients react with the arthritis-related autoantigen 60S ribosomal protein L23a (RPL23A). RESULTS: A subpopulation of patients with early RA harbored intestinal microbiota dominated by Prevotella copri; SKG mice harboring microbiota from RA patients had an increased number of intestinal Th17 cells and developed severe arthritis when treated with zymosan. Lymphocytes in regional lymph nodes and the colon, but not the spleen, of these mice showed enhanced interleukin-17 (IL-17) responses to RPL23A. Naive SKG mouse T cells cocultured with P copri-stimulated dendritic cells produced IL-17 in response to RPL23A and rapidly induced arthritis. CONCLUSION: We demonstrated that dysbiosis increases sensitivity to arthritis via activation of autoreactive T cells in the intestine. Autoreactive SKG mouse T cells are activated by dysbiotic microbiota in the intestine, causing joint inflammation. Dysbiosis is an environmental factor that triggers arthritis development in genetically susceptible mice.


Asunto(s)
Artritis Experimental/inmunología , Artritis Reumatoide/inmunología , Disbiosis/inmunología , Microbioma Gastrointestinal/inmunología , Intestinos/inmunología , Linfocitos T/inmunología , Células Th17/inmunología , Anciano , Animales , Artritis Experimental/inducido químicamente , Artritis Experimental/microbiología , Artritis Reumatoide/microbiología , Autoantígenos/inmunología , Autoinmunidad/inmunología , Estudios de Casos y Controles , Colon/inmunología , ADN Bacteriano/genética , Femenino , Microbioma Gastrointestinal/genética , Humanos , Interleucina-17/inmunología , Intestinos/microbiología , Ganglios Linfáticos/inmunología , Masculino , Ratones , Persona de Mediana Edad , ARN Ribosómico 16S/genética , Proteínas Ribosómicas/inmunología , Bazo/inmunología , Zimosan/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA